Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Russo

Showing results (61-70 of 427) with videos related to

Pageof 43
Sort By:
Urology|January 1, 2016
ReplyPaul Russo
European Urology Oncology|April 25, 2019
Kidney Cancer and Surgical Metastasectomy: Effective Therapy or Part of Disease Natural History?Paul Russo
European Urology Open Science|February 14, 2023
The Decision to Surgically Resect Recurrent Renal Cell Carcinoma: More Evidence that Careful Case Selection by Surgeons Is Associated with Better SurvivalPaul Russo
Urology|April 21, 2020
Historical Perspective on Partial Nephrectomy and Renal Functional PreservationPaul Russo
Urology|November 12, 2022
EDITORIAL COMMENTPaul Russo
The Urologic Clinics of North America|November 11, 2008
The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumorsPaul Russo, William Huang
Archivos Espanoles De Urologia|February 15, 2013
Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate?Preston Sprenkle, Paul Russo
Korean Journal of Urology|September 20, 2014
Open mini-flank partial nephrectomy: an essential contemporary operationPaul Russo, Roy Mano
Urologic Oncology|March 4, 2019
The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinomaPiotr Zareba, Paul Russo
Urology|January 15, 2015
Reply: To PMID 25586475Roy Mano, Paul Russo
Pageof 43

Showing results (61-70 of 427) with videos related to

Sort By:
Pageof 43
Urology|January 1, 2016
ReplyPaul Russo
European Urology Oncology|April 25, 2019
Kidney Cancer and Surgical Metastasectomy: Effective Therapy or Part of Disease Natural History?Paul Russo
European Urology Open Science|February 14, 2023
The Decision to Surgically Resect Recurrent Renal Cell Carcinoma: More Evidence that Careful Case Selection by Surgeons Is Associated with Better SurvivalPaul Russo
Urology|April 21, 2020
Historical Perspective on Partial Nephrectomy and Renal Functional PreservationPaul Russo
Urology|November 12, 2022
EDITORIAL COMMENTPaul Russo
The Urologic Clinics of North America|November 11, 2008
The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumorsPaul Russo, William Huang
Archivos Espanoles De Urologia|February 15, 2013
Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate?Preston Sprenkle, Paul Russo
Korean Journal of Urology|September 20, 2014
Open mini-flank partial nephrectomy: an essential contemporary operationPaul Russo, Roy Mano
Urologic Oncology|March 4, 2019
The prognostic significance of nodal disease burden in patients with lymph node metastases from renal cell carcinomaPiotr Zareba, Paul Russo
Urology|January 15, 2015
Reply: To PMID 25586475Roy Mano, Paul Russo
Pageof 43